AP NEWS

Autoimmune & Inflammation: Disease & Epidemiology Overviews - 2018 Report - ResearchAndMarkets.com

November 27, 2018

DUBLIN--(BUSINESS WIRE)--Nov 27, 2018--The “Autoimmune & Inflammation: Disease & Epidemiology Overviews” report from Decision Resources Group has been added to ResearchAndMarkets.com’s offering.

Autoimmune & Inflammation: Disease & Epidemiology Overview, provides disease market overviews and global epidemiology overviews for 18 indications in the Autoimmune & Inflammation therapy area:

Atopic Dermatitis/Atopic Eczema Psoriasis Crohn’s Disease Irritable Bowel Syndrome Ulcerative Colitis Acute Respiratory Distress Syndrome Asthma Chronic Obstructive Pulmonary Disease Cystic Fibrosis Idiopathic Pulmonary Fibrosis Axial Spondyloarthritis Juvenile Idiopathic Arthritis Psoriatic Arthritis Rheumatoid Arthritis Scleroderma (Systemic Sclerosis) Sjogren’s Syndrome Systemic Lupus Erythematosus Graft Versus Host Disease

This report provides a disease market overview for each indication and global epidemiology overviews for each indication. The disease market overviews include information such as market size forecasts, prevailing treatment trend analysis and predictions, key areas of unmet need, current and emerging therapies, physician (KOL) insights, clinical pipeline analysis, and more, for each indication.

The global epidemiology overviews provide insights including global diagnosed prevalence, diagnosed prevalence by region, 10-year diagnosed prevalence growth forecast, relative sizes of the factors contributing to the trend in prevalent cases, and more, for each indication.

Companies Featured

Boehringer Ingelheim FibroGen Mallinckrodt Promedior Prometic Life Sciences Roche

Key Topics Covered

1. Disease Landscape and Insight Overview 2. Epidemiology Overview 3. About the Authors & Epidemiologists

For more information about this report visit https://www.researchandmarkets.com/research/wzvg5k/autoimmune_and?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181127005555/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Immune Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/27/2018 09:45 AM/DISC: 11/27/2018 09:46 AM

http://www.businesswire.com/news/home/20181127005555/en

AP RADIO
Update hourly